136 results about "Cannabis" patented technology

A harvester for removing cannabis flower from stalks includes a blade follower iris that adjusts the size of the flower-stripping opening to correspond to the diameter of the stalk. The size of the opening may be controlled by centrifugal and spring forces that cause the iris to open and close. In addition, an improved stalk-pulling belt drive conveyor system utilizes two relatively floating, releasably coupled belt systems to pinch and pull the stalk through the blade follower iris.

The invention relates to methods of identifying and characterizing a Cannabis spp. plant comprising a quantitative trait locus (QTL) or a causal polymorphism associated with a flower density trait, and to Cannabis spp. plants having a flower density trait of interest comprising defined allelic states of polymorphisms defining the QTL or defined allelic states of causal polymorphisms provided herein. Also provided are Cannabis spp. plants with a flower density trait of interest comprising defined allelic states of polymorphisms and plants identified, characterized or produced by the methods described. Further provided are methods of marker assisted selection, genomic selection, marker assisted breeding, and genetic modification, for obtaining plants having a flower density trait of interest.

The present invention relates to an extract of in vitro cultured C. sativa root tissues, characterized in that said extract comprises at least one lignanamide. The present invention also relates to a pharmaceutical, dermatological, nutraceutical, or cosmetic composition comprising, as an active ingredient, the extract described above.

Apparatuses and methods to dry, rehydrate, cure, and / or burp products, such as, for example cannabis buds and / or flowers. In certain aspects, the apparatuses comprise an apparatus with a bottom, at least one sidewall, and a removable top to access an internal storage compartment. A dry rack is secured in the internal storage compartment above the bottom to generally separate the internal storage compartment of the apparatus into a sump part and a product part. A fan, located in a sidewall, is configured to pump air into the pump part of the apparatus. The dry rack is configured to hold product above the sump such that the air pumped by the fan circulates in the sump and rises through the dry rack and product to dry, cure, or rehydrate the product.

The invention provides a pharmaceutical composition for improving the salt tolerance of industrial cannabis sativa and a method for improving the salt tolerance of the industrial cannabis sativa, and belongs to the technical field of agriculture. The invention provides a pharmaceutical composition for improving the salt tolerance of industrial cannabis sativa. The pharmaceutical composition comprises salicylic acid and abscisic acid which are separately subpackaged, the mass ratio of the salicylic acid to the abscisic acid is 1: (0.8-1.2). The invention further provides a method for improving the salt tolerance of the industrial hemp, salicylic acid and abscisic acid are alternately and circularly applied to the industrial hemp, the yellowing degree of leaves of the industrial hemp under the salt stress condition can be effectively reduced, meanwhile, extension of the leaves of the industrial hemp is promoted, the plant height, stem diameter, biomass and chlorophyll relative content of the industrial hemp are improved, and the salt tolerance of the industrial hemp is improved. And the method has important significance on salt-tolerant cultivation of industrial hemp.

The present invention describes a method for the large-scale production of Cannabis sp. seedlings using the mini-cuttings technique. The process involves establishing a clonal mini-garden with super-dense planting of mini-stock plants trained in a "cup" form, optimizing use of the available space and significantly increasing productivity per unit area. An inert substrate is used, such as sand and expanded perlite, although variations such as vermiculite, carbonized rice husk, or coconut fiber can be employed without compromising efficiency. Environmental control is automated, ensuring ideal conditions of temperature, humidity, and photoperiod, maintained by means of artificial lighting, such as full-spectrum LED lamps operating for at least 18 hours per day to keep the plants in a continuous vegetative state. The invention offers significant advantages in terms of efficiency, genetic quality, sustainability, and reduction of operating costs, meeting the demands of the medicinal and industrial markets for high-quality Cannabis sp. products. By enabling the accelerated production of uniform clonal seedlings, the method has the potential to revolutionize cannabis cultivation practices.

The present disclosure relates to compositions and methods related to modification of trichome density and transport of metabolite and their uses in plants, including tobacco and cannabis. The provided transcription factors enable the increase in trichome density in plants.

A gas jet sieve trichome separation assembly is employed in use to separate trichomes from source plant material, such as separating kief from cannabis source plant material. The gas jet sieve trichome separation assembly, as well as an associated method of its operation, serves to separate and collect trichomes in a manner that has proven more effective and efficient than past techniques, and in a manner that facilitates enhanced automation and that is intended for larger scale production capabilities. Per various implementations, the gas jet sieve trichome separation assembly has a housing, one or more sieves, one or more rotatable arms, one or more actuators, a vacuum source, and a cyclonic separator.

The invention relates to a preparation method of fructus cannabis active polypeptide, which comprises the following steps: soaking degreased fructus cannabis meal in water for several hours, fishing out, freezing and melting twice, grinding into thick liquid, adding bromelain into the thick liquid for hydrolysis, and after the first hydrolysis, adding aspergillus niger acid protease for second hydrolysis; and after the secondary hydrolysis is finished, carrying out enzyme deactivation on the hydrolysate, centrifuging to remove unhydrolyzed precipitates, taking supernate, collecting filtrate by using a 2000Da ultrafiltration device, and concentrating and drying the filtrate to obtain the fructus cannabis active polypeptide powder. The fructus cannabis active polypeptide prepared by the preparation method disclosed by the invention has the effects of exciting the activity of ethanol dehydrogenase and inhibiting the activity of tyrosinase, and can be used as a raw material of functional food or cosmetics.

A transdermal composition can include a cannabis particulate blend including THCA, CBD, and male and female reproductive cells, wherein the cannabis particulate blend has a particle size distribution within a range of about 120 µm to about 400 µm, and wherein the THCA is present in the transdermal composition at from about 0.01 wt% to about 0.5 wt% THCA and the CBD is present in the transdermal composition at from about 1 wt% to about 10 wt% CBD. The transdermal composition can further include from about 1 wt% to about 10 wt% lion's mane mushroom, and from about 50 wt% to about 85 wt% coconut oil and / or butter and about 5 wt% to about 20 wt% beeswax based on a total weight of the transdermal composition. The THCA in this example is prepared to include particles from both the male plant and the female plant.

Provided herein is the identification of markers and genes associated with flower initiation in Cannabis. The markers are useful for breeding Cannabis plants that initiate flowering at longer daylengths, which allow for earlier maturation and harvesting and ability to grow outdoors at different latitudes or in greenhouses without artificial light deprivation. Also provided are methods for selecting plants by obtaining nucleic acids and detecting one or more markers that indicate flower initiation at increased daylight hours in order to establish plant lines having shorter harvest period as a result of flowering at increased daylight hours.

The present invention relates to the process of enrichment of Phytocannabinoids namely CBD and Δ9-THC from the dried aerial part (leaves and inflorescence) of Cannabis sativa. The present invention also relates to the preparation of formulation having enriched CBD and THC by combining with appropriate acceptable excipients such as nutriose, dextrin and maltodextrin. The present invention also discloses the use of the phytocannabanoids enriched blend for the management of pain including cancer pain & general pain.

The invention relates to methods of identifying and characterizing a Cannabis spp. plant with respect to a flowering time trait comprising genotyping the plant for a quantitative trait locus (QTL) associated with a flowering time trait, and to methods of producing plants having a flowering time trait of interest based on defined allelic states of polymorphisms defining the QTL. Also provided are Cannabis spp. plants having a flowering time trait of interest comprising defined allelic states of polymorphisms defining the QTL and plants identified, characterized or produced by the methods described herein. The invention further relates to marker assisted selection and marker assisted breeding methods, in particular using a combination of specific markers provided, for obtaining plants having a flowering time trait of interest or for modulating the flowering time of cannabis plants.

Methods and apparatus for sterilizing plant material include disposing plant material in a sub-atmospheric pressure environment, dispersing a non-toxic, non-polymerizable gas into the sub-atmospheric pressure environment, applying an electric field to change the gas into cold plasma, and maintaining exposure of the plant material to the cold plasma until substantially sterilized plant material is obtained, wherein an amount of at least one active constituent in the plant material is substantially unchanged by the sterilizing. The plant material may be cannabis.

The invention provides an industrial hemp plant hydroponic nutrient solution and application thereof, and belongs to the technical field of plant cultivation. Comprising the following raw materials in parts by weight: 8 to 12 parts of EM (Effective Microorganisms) fermentation liquor, 1 to 3 parts of compound amino acid, 30 to 40 parts of Hoagland nutrient solution, 4 to 6 parts of humic acid, 0.04 to 0.07 part of chitosan, 0.01 to 0.03 part of chlorogenic acid and 0.01 to 0.03 part of ferulic acid. The plant hydroponic nutrient solution provided by the invention can promote rooting and stem and leaf growth of cannabis sativa, and can also increase the content of effective components. Compared with an existing Hoagland nutrient solution, the plant hydroponic nutrient solution provided by the invention has a more obvious growth promoting effect on cannabis sativa.

Provided herein is the identification and markers and causal genes associated with day-neutral autoflowering in plants and their use in selecting plants, including Cannabis plants, having autoflowering activity. The markers are useful for breeding autoflowering plants by obtaining nucleic acids, detecting one or more markers that indicate autoflowering activity, and establishing plant lines having such characteristics. Also provided are methods of editing plants to establish plant lines having autoflowering allelic variations.

The application discloses a method for ultrasonic regulation and control of functional properties of acidified cannabis sativa L. protein and application thereof. The application fully hydrates the cannabis sativa L. protein under acidification conditions, combines ultrasonic pretreatment, and performs heat induction to make the protein have ordered aggregation with enriched beta-folding, and meanwhile, improve the functional properties of the protein: the gel strength is 12.37 g under 60% ultrasonic power, which is about 33% higher than that of a non-ultrasonic control, the cohesiveness is 8.6 g, the emulsion stability is 185.89 min, which is about 2.6 times higher than that of the non-ultrasonic control, the apparent viscosity is improved and presents shear thinning behavior (power law index n1 < 1), and the strain breakage resistance is enhanced. The method can simultaneously regulate and control the ordered aggregation degree, gel property, emulsification and rheological property of the cannabis sativa L. protein, is suitable for strong acid type plant protein beverages, acid emulsions and high-acid gel food systems, and has the advantages of simple process, green safety and the like.

This invention relates to a novel cannabinoid oral pharmaceutical dosage form based on a Type IV or Type IV-like formulation classified using a Lipid Formulation Classification System. The formulation is contained in a container. "Type IV-like" means that the formulation is oil-free, for example, free of triglycerides or mixed glycerides.

A method for packaging Cannabis includes placing a first Cannabis mixture into a first capsule mold of a tray. The method also includes pressing the first Cannabis mixture into a first inside surface of the first capsule mold to form a first Cannabis puck. The first inside surface is rounded in two directions. The method also includes attaching a first cover to the tray to cover the first Cannabis puck in the first capsule mold.

The present invention relates to a composition for protecting nerve cells, comprising a supercritical extract of Cannabis sativa and, more specifically, to a composition for protecting nerve cells, comprising a supercritical extract of Cannabis sativa, thereby exhibiting an antioxidant effect and a nerve cell death inhibitory effect.

The invention provides an umbilicus application suppository for treating constipation and a preparation method thereof, and relates to the technical field of medicine.The umbilicus application suppository for treating constipation comprises a suppository body, the suppository body comprises a suppository matrix and a traditional Chinese medicine microcapsule, and the traditional Chinese medicine microcapsule comprises an emulsified oil phase, an emulsified water phase and a traditional Chinese medicine composition; the traditional Chinese medicine composition comprises rheum officinale, fructus cannabis, bunge cherry seeds, astragalus membranaceus, ginseng, immature bitter oranges, mangnolia officinalis, rhizoma atractylodis, radix sophorae flavescentis, golden cypress, fructus cnidii and fructus evodiae. A transdermal promotion mechanism is designed and optimized by adopting a traditional Chinese medicine micro-capsule structure, and a specific traditional Chinese medicine composition and a micro-encapsulation process are combined, so that the transdermal absorption efficiency of the medicine is effectively improved, the skin irritation reaction is reduced, and meanwhile, the stable slow release of the medicine is realized, thereby solving the problems of low transdermal absorption efficiency, large effect fluctuation, poor skin compatibility and the like in the prior art; the preparation has the advantages of high transdermal absorption efficiency, small skin irritation, good drug sustained release performance and the like.

This document describes methods and compositions for preventing hermaphroditism in Cannabis plants, as well as methods and compositions for making male sterile Cannabis plants.

Provided herein are methods of characterizing and identifying a Cannabis spp. plant comprising quantitative trait loci (QTLs) associated with a purple color trait of interest, and methods of producing plants having a purple color trait of interest based on defined allelic states of polymorphisms defining the QTLs. Also provided are Cannabis spp. plants with the purple color trait of interest comprising defined allelic states of polymorphisms defining the QTLs and plants identified, characterized or produced by the methods described herein. Further provided are methods of marker assisted selection, genomic selection and marker assisted breeding, in particular using a combination of specific markers provided, for obtaining plants having a purple color trait of interest.

The present invention discloses systems, devices, and methods for symphasic closed-cycle heat exchange, applicable to processes for extraction of compounds from biological materials, such as cannabis and other plants; said systems, devices, and methods incorporating a closed-cycle refrigeration circuit to provide energy savings and other improvements over existing single loop closed-cycle extraction processes.

System and method for infusing cannabis flower with one or more terpenes, THC, CBD, or any combination thereof. Embodiments include tumbling cannabis flower in a rotating treatment vessel, such as in a closed-loop system, while exposing the cannabis flower to an atomized liquid comprising one or more terpenes, THC distillate, or CBD distillate.

The application discloses a traditional Chinese medicine composition for treating constipation, which is prepared from the following traditional Chinese medicine extracts: 20-30 parts of radix rehmanniae preparata, 15-25 parts of fructus corni, 10-20 parts of radix scrophulariae, 10-20 parts of radix ophiopogonis, 10-20 parts of prunus domestica, 9-15 parts of semen platycladi, 10-20 parts of semen cannabis, 4-6 parts of semen abri, 10-20 parts of bombyx batryticatus, 8-12 parts of angelica sinensis, 8-12 parts of salvia miltiorrhiza, 3-8 parts of prunus armeniaca, 8-12 parts of platycodon grandiflorum, 8-12 parts of fructus aurantii, 9-12 parts of pericarpium citri reticulatae, 4-8 parts of glycyrrhiza uralensis, and a preparation method thereof is disclosed. The application is used for treating constipation of the type of dry intestine due to yin deficiency by the treatment principles of tonifying kidney yin, tonifying heart yin, moistening the intestines, moistening the intestines with pungent flavor, promoting lung and regulating qi, lifting the cover of the pot, regulating qi and invigorating the spleen, and regulating and protecting the spleen and stomach.

The invention provides a traditional Chinese medicine composition for treating senile chronic functional constipation, which is prepared by extracting the following traditional Chinese medicines in parts by weight: 4-8 parts of prepared rhubarb, 8-12 parts of angelica sinensis, 10-20 parts of astragalus membranaceus, 8-12 parts of codonopsis pilosula, 6-12 parts of immature bitter orange, 4-8 parts of cimicifugae foetidae, 8-12 parts of radix rehmanniae recen, 4-8 parts of rhizoma anemarrhenae, 4-8 parts of platycodon grandiflorum, 6-12 parts of aster, 4-8 parts of fructus cannabis and 4-8 parts of almond. The traditional Chinese medicine composition is mainly used for dispersing blood stasis and promoting blood circulation, and is also used for tonifying qi, promoting blood circulation and nourishing blood, so that qi and blood in intestinal tracts are smooth, the functions of nourishing and conduction are self-recovered, and constipation is relieved. The invention also discloses a preparation method and application of the traditional Chinese medicine composition.

Provided is use of MfERF026 regulation in growth, development, and stress tolerance of Medicago sativa, which belongs to the technical field of plant genetic engineering. Provided is use of a regulatory agent for MfERF026, which is an ethylene responsive factor (ERF) in Medicago falcata, in promoting growth and development and improving drought tolerance and cold tolerance of M. sativa. The inhibited expression of MfERF026, the ERF in M. falcata may enhance the drought tolerance and cold tolerance of the M. sativa. Moreover, the inhibited expression of MfERF026, the ERF in M. falcata, may regulate the growth and development of M. sativa, thereby accelerating the growth rate of M. sativa to increase the number of leaves. The inhibited expression of MfERF026 provides a novel theoretical basis and a candidate gene for cultivating novel leguminous forage varieties with high resistance, yield, and protein content.

The invention relates to methods of identifying and characterizing a Cannabis spp. plant comprising a quantitative trait locus (QTL) or a causative polymorphism associated with pathogen resistance, and to Cannabis spp. plants having a pathogen resistance trait of interest comprising defined allelic states of polymorphisms defining the QTL. Also provided are plants with a pathogen resistance trait of interest identified by the methods described herein. The invention further relates to marker assisted selection and marker assisted breeding methods for obtaining plants having a pathogen resistance trait of interest, as well as to methods of producing Cannabis spp. plants with the pathogen resistance trait of interest and plants produced by these methods, based on the allelic state of the QTLs or the causative polymorphism.